FinTrust Capital Advisors’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $30.2K | Hold |
712
| – | – | 0.01% | 707 |
|
|
2024
Q2 | $28.7K | Buy |
712
+100
| +16% | +$4.03K | 0.01% | 666 |
|
|
2024
Q1 | $21.7K | Buy |
+612
| New | +$21.7K | ﹤0.01% | 703 |
|
|
2023
Q4 | – | Sell |
-110
| Closed | -$2.29K | – | 1309 |
|
|
2023
Q3 | $2.29K | Sell |
110
-20
| -15% | -$415 | ﹤0.01% | 988 |
|
|
2023
Q2 | $5.84K | Hold |
130
| – | – | ﹤0.01% | 837 |
|
|
2023
Q1 | $5.84K | Hold |
130
| – | – | ﹤0.01% | 833 |
|
|
2022
Q4 | $5.84K | Hold |
130
| – | – | ﹤0.01% | 835 |
|
|
2022
Q3 | $7K | Hold |
130
| – | – | ﹤0.01% | 965 |
|
|
2022
Q2 | $8K | Sell |
130
-625
| -83% | -$38.5K | ﹤0.01% | 954 |
|
|
2022
Q1 | $88K | Hold |
755
| – | – | 0.02% | 449 |
|
|
2021
Q4 | $114K | Hold |
755
| – | – | 0.03% | 392 |
|
|
2021
Q3 | $90K | Buy |
755
+20
| +3% | +$2.38K | 0.02% | 441 |
|
|
2021
Q2 | $72K | Buy |
735
+210
| +40% | +$20.6K | 0.02% | 493 |
|
|
2021
Q1 | $46K | Sell |
525
-2,605
| -83% | -$228K | 0.01% | 549 |
|
|
2020
Q4 | $299K | Buy |
3,130
+1,230
| +65% | +$117K | 0.1% | 178 |
|
|
2020
Q3 | $215 | Sell |
1,900
-922
| -33% | -$104 | 0.04% | 217 |
|
|
2020
Q2 | $279K | Buy |
2,822
+1,088
| +63% | +$108K | 0.11% | 161 |
|
|
2020
Q1 | $111K | Buy |
1,734
+649
| +60% | +$41.5K | 0.05% | 280 |
|
|
2019
Q4 | $65K | Buy |
1,085
+918
| +550% | +$55K | 0.03% | 395 |
|
|
2019
Q3 | $10K | Sell |
167
-1
| -0.6% | -$60 | ﹤0.01% | 742 |
|
|
2019
Q2 | $11K | Buy |
168
+93
| +124% | +$6.09K | ﹤0.01% | 715 |
|
|
2019
Q1 | $5K | Sell |
75
-33
| -31% | -$2.2K | ﹤0.01% | 942 |
|
|
2018
Q4 | $4K | Buy |
+108
| New | +$4K | ﹤0.01% | 988 |
|